GlassScriptPhysician profile
Hector W Ho
NPI 1912969353
$7,311.52
in general payments reported to CMS, 2019-2025
22 companies · $696 in 2025
The $696 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $786 · 2020: $2,591 · 2021: $356 · 2022: $696 · 2023: $948 · 2024: $1,239 · 2025: $696.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,842 · Travel and Lodging: $541 · Consulting Fee: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,841.86 |
| Travel and Lodging | $541.08 |
| Consulting Fee | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $1,676.19 | 2019-2025 | Cusa Clarity, Codman Hakim, Duraseal Exact Spinal Sealant System |
| Medtronic USA, INC. | $1,545.97 | 2020 | |
| Globus Medical, INC. | $1,274.97 | 2019-2025 | Stretto, Independence, Acadia |
| Medtronic, INC. | $732.23 | 2021-2024 | Pivox Oblique Lateral Spinal System, Anteralign Spinal System With Titan Nanolock Surface Technology, Mazor X System |
| Monteris Medical Corporation | $701.29 | 2019-2024 | Neuroblate |
| Depuy Synthes Sales INC. | $297.77 | 2019-2022 | |
| Mizuho America, INC. | $215.89 | 2019-2022 | |
| Spineart USA INC | $179.18 | 2022-2023 | Perla Tl |
| Actelion Pharmaceuticals US, INC. | $122.14 | 2019 | |
| Nuvasive, INC. | $103.05 | 2023 | Pulse |
| Gt Medical Technologies, INC | $81.85 | 2019 | |
| Integrity Implants INC. Dba Accelus | $77.07 | 2023 | |
| Stryker Corporation | $63.41 | 2019-2025 | Hydroset, Universal Neuro 3 |
| Icotec Medical INC. | $57.51 | 2025 | Kong-Tl Vbr E, Expandable Body, L, 19 Mm X 27 - 37 Mm, Kong-Tl Vbr, End Plate, Rectangular, M and Screw, 12 X 33 Mm, Vader Pedicle System 6.0, Screw, Carbon/Peek, Polyax., Fen., O 5.5 X 45 Mm |
| Aesculap, INC. | $36.32 | 2024 | Progav 2.0 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Breg, INC | $28.01 | 2023 | Breg Vpulse, Plasmaflow, Polarcarewave |
| Biocomposites INC | $27.92 | 2024 | |
| Abbvie INC. | $25.37 | 2023 | |
| Nevro Corp. | $23.13 | 2024 | Senza |
| Valinor Pharma, LLC | $21.70 | 2023 | Movantik |
| Titan Spine, LLC | $20.55 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hector Ho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.